Member States reach agreement on Framework Programme for Research and Innovation in Europe
The political agreement is based on the Commission's amended proposal for FP7 and carries a total budget of EUR 54.6 billion, which means approximately EUR 7 billion per year for research compared to EUR 5 billion under FP6. SMEs and Public non-profit organizations will also get 75% of their costs funded compared to 50% under FP6. The new Framework Programme provides a boost for biotech companies to fund their innovative research in key areas such as Health, Food, Agriculture, Energy and Environment.
EuropaBio, the European Association for Bioindustries, welcomes the EU Competitiveness Council political agreement "EuropaBio is pleased with the Council's position on FP7. Although we do remain disappointed that Member States have reduced the overall budget initially proposed by the Commission, we are strongly convinced that the implementation of FP7 will provide a significant contribution to the competitiveness of the European bio-industry, as well as to the public welfare and economic growth across Europe", says Dr. Johan Vanhemelrijck, Secretary General of EuropaBio.
EuropaBio also welcomes the agreement on stem cell research allowing the funding of embryonic stem cell projects on a case-by-case basis, depending on the laws of member states involved, the contents of the scientific proposal and the evaluation of the ethical committee.
Most read news
Organizations
Other news from the department politics & laws
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.